RECENT COST TRENDS AMONG PATIENTS USING BIOLOGIC AGENTS FOR THE TREATMENT OF PSORIATIC ARTHRITIS

被引：0
|
作者：
Kuznik, A. [1 ]
Eslava, S. [2 ]
Cai, J. [3 ]
机构：
[1] Celgene Corp, Warren, NJ USA
[2] Celgene Corp, Berkeley Hts, NJ USA
[3] Celgene Corp, Summit, NJ USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.914
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS29
引用
收藏
页码：A157 / A157
页数：1
相关论文
共 50 条
  • [41] Clinical and cost implications of the BSR guidelines on biologic therapy for psoriatic arthritis
    Wong, L. L.
    Baxter, R. D.
    McCarey, D. W.
    Hunter, J. A.
    RHEUMATOLOGY, 2006, 45 : I67 - I67
  • [42] Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
    Arthur Kavanaugh
    Rakesh Singh
    Chitra Karki
    Carol J. Etzel
    Joel M. Kremer
    Jeffrey D. Greenberg
    Jenny Griffith
    Clinical Rheumatology, 2018, 37 : 2275 - 2280
  • [43] Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
    Kavanaugh, Arthur
    Singh, Rakesh
    Karki, Chitra
    Etzel, Carol J.
    Kremer, Joel M.
    Greenberg, Jeffrey D.
    Griffith, Jenny
    CLINICAL RHEUMATOLOGY, 2018, 37 (08) : 2275 - 2280
  • [44] Variations in treatment patterns, disease status and outcomes among patients with psoriatic arthritis receiving their first biologic in European union
    Narayanan, S.
    Baskett, A.
    Lu, Y.
    Hutchings, R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 54 - 54
  • [45] Treatment with Biologic Agents Improves the Prognosis of Patients with Rheumatoid Arthritis and Amyloidosis
    Kuroda, Takeshi
    Tanabe, Naohito
    Kobayashi, Daisuke
    Sato, Hiroe
    Wada, Yoko
    Murakami, Shuichi
    Saeki, Takako
    Nakano, Masaaki
    Narita, Ichiei
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (07) : 1348 - 1354
  • [46] TREATMENT WITH BIOLOGIC AGENTS IMPROVES THE PROGNOSIS OF PATIENTS WITH RHEUMATOID ARTHRITIS AND AMYLOIDOSIS
    Kuroda, T.
    Kobayashi, D.
    Sato, H.
    Nakatsue, T.
    Wada, Y.
    Murakami, S.
    Nakano, M.
    Narita, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 103 - 103
  • [47] REAL-WORLD TREATMENT PERSISTENCE WITH BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS AMONG GERMAN PATIENTS WITH PSORIATIC ARTHRITIS
    Sewerin, P.
    Borchert, K.
    Meise, D.
    Mahlich, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1172 - 1172
  • [48] Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-α blocking) agents in the treatment of psoriatic arthritis
    Salvarani, C
    Olivieri, I
    Pipitone, N
    Cantini, F
    Marchesoni, A
    Punzi, L
    Scarpa, R
    Matucci-Cerinic, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (01) : 70 - 78
  • [49] Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
    Jashin J. Wu
    Corey Pelletier
    Brian Ung
    Marc Tian
    Ibrahim Khilfeh
    Jeffrey R. Curtis
    Advances in Therapy, 2020, 37 : 2098 - 2115
  • [50] Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
    Palmer, Jacqueline B.
    Li, Yunfeng
    Herrera, Vivian
    Liao, Minlei
    Tran, Melody
    Ozturk, Zafer E.
    BMC MUSCULOSKELETAL DISORDERS, 2016, 17
12345